Resultado de búsqueda
Hace 20 horas · According to the agency, in 2021 one PBM was billing payers almost 250 times its acquisition cost for one of the drugs: generic Gleevec, which is used to treat leukemia.
Hace 4 horas · CVS said its members pay on average less than $8 for a 30-day prescription. Limits on PBMs would benefit drugmakers, the company said in a statement after the FTC issued its report. A representative for Cigna’s Express Scripts said the agency’s “biased conclusions” won’t address rising drug prices. Humana declined to comment.
Hace 20 horas · Concentration and vertical integration among the country’s top entities managing prescription drug benefits could be responsible for inflating drug costs and creating financial difficulties for independent pharmacies, according to a recent FTC staff report.. The interim report highlights preliminary findings from the Federal Trade Commission’s study on the six largest pharmacy benefit ...
Hace 8 horas · FTC staff examined cases of generic Zytiga for prostate cancer and generic Gleevec for leukemia and found pharmacies affiliated with the top three PBMs received high gross reimbursement rates from the health plans the PBMs manage—often ranging from 20 to 40 times higher than the national average drug acquisition cost (NADAC).
Hace 20 horas · Prescription drug middlemen took in nearly $1.6 billion in extra revenue on two cancer drugs in less than three years, by steering business to affiliated pharmacies, a new Federal Trade Commission report finds.. Why it matters: The findings underscore the degree to which vertical integration and concentration among pharmacy benefit managers allow the companies to influence the drug supply ...
Hace 20 horas · We dive into the archive of 2019 for insight and inspiration – this time with Bruce Levine. When Bruce Levine, Professor in Cancer Gene Therapy at the University of Pennsylvania, finished his graduate work, there wasn’t really a cell and gene therapy field to speak of. In fact, he was part of the force that helped build it from the ground up.
Hace 20 horas · Acute myeloid leukemia (AML) is characterized by the uncontrolled proliferation of myeloid leukemia cells in the bone marrow and other hematopoietic tissues and is highly heterogeneous. While with the progress of sequencing technology, understanding of the AML-related biomarkers is still incomplete. The purpose of this study is to identify potential biomarkers for prognosis of AML. Based on ...
